Navigation Links
Boehringer Ingelheim Enrolls First Patients in Pivotal Phase 3 Interferon-Free Hepatitis C Trial Program
Date:1/17/2013

o™ studies are expected in late 2013.

For more information regarding the trials, please visit www.clinicaltrials.gov.

About Boehringer Ingelheim in Hepatitis C Virus (HCV)
In partnership with the scientific community, our clinical trial program, HCVerso™, is rigorously designed to find answers to the challenges that HCV patients face, including those who are the most difficult to treat.

Faldaprevir, also known as BI 201335, is an investigational, oral HCV NS3/4A protease inhibitor that may improve viral cure rates as compared to PegIFN/RBV therapy alone, and has completed clinical trials through Phase 2b (SILEN-C studies). Faldaprevir is designed to target the hepatitis C viral reservoir in the liver and inhibit viral replication. The ongoing multi-study Phase 3 STARTVerso™ trial program, evaluating faldaprevir combined with PegIFN/RBV in treatment-naive, treatment-experienced and HIV co-infected patients with chronic genotype-1 HCV, is near clinical completion. BI 207127 is an investigational NS5B non-nucleoside polymerase inhibitor that has shown the potential to eliminate interferon from HCV treatment when combined in a regimen with faldaprevir and RBV. Phase 2 trials of this interferon-free regimen have been completed and Phase 3 HCVerso™ trials investigating this regimen are now underway.

Faldaprevir and BI 207127 are investigational compounds and not approved by the FDA. Their safety and efficacy have not been established.

Hepatitis C is a blood-born infectious disease and a leading cause of chronic liver disease, transplant and failure that affects as many as 150 million people globally. In the United States, an estimated 4.1 million Americans have been infected with HCV, of which approximately 3.2 million have chronic HCV infection. Since 1999 there has been a significant increase in deaths due to ch
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Boehringer Ingelheim Presents New Phase II Data for Volasertib in Adult Patients with AML
2. Boehringer Ingelheim Announces Equine Research Awards
3. Phase 2b Data of Boehringer Ingelheims Interferon-Free Hepatitis C Treatment Show Viral Cure Achieved in Up to 85% of Treatment-Naive Patients
4. Whistleblowers extraordinary efforts helped win $95 million settlement with Boehringer Ingelheim
5. Boehringer Ingelheim announces afatinib expanded access program (EAP) for patients with EGFR mutation-positive advanced NSCLC
6. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
7. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
8. Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
9. Results of Phase II Study of Boehringer Ingelheims Investigational Bronchodilator for COPD Presented at 2012 ATS International Conference
10. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
11. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... -- Research and Markets ( ... "Veterinary Pharmaceutical Submissions in the EU (London, ... their offering. This practical two-day course ... parts of the application for marketing authorisation for ... authorisation is sought in the European Union, including ...
(Date:9/4/2015)... , September 4, 2015 ... announces that Hutchison MediPharma Limited ("HMP"), its drug ... the second proof-of-concept ("POC") trial of fruquintinib in ... ("NSCLC") in China .  The ... in meeting the primary efficacy endpoint of progression ...
(Date:9/3/2015)... a population of more than 1 billion, China is ... largest potential market for goods and services. In the ... economies in the average rate of growth in real ... an in vitro diagnostics (IVD) market, China trails only ... European countries, and Japan. China represents one of the ...
Breaking Medicine Technology:Veterinary Pharmaceutical Submissions in the EU: Two day Course - London, UK - December 7-8, 2015 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 3IVD in China 2IVD in China 3IVD in China 4IVD in China 5IVD in China 6IVD in China 7IVD in China 8IVD in China 9IVD in China 10IVD in China 11IVD in China 12IVD in China 13
... RANCHO MIRAGE, Calif., March 30, 2011 Eisenhower Medical ... to help ensure patient privacy and security after a ... burglary on Friday, March 11. The computer ... electronic index with limited patient information used by EMC. ...
... Itchy, runny nose, sneezing, watery eyes and itchy ... make our children miserable from allergies. And just in ... allergy season, PediaCare® , a trusted brand of ... century, is introducing new one-dose per day, Children,s PediaCare® ...
Cached Medicine Technology:Eisenhower Medical Center Reports Theft of Computer and Television 2Allergy Relief Moms Can Rely On 2
(Date:9/4/2015)... ... September 04, 2015 , ... With TransCel from Pixel Film Studios ... Final Cut Pro X. With TransCel users have full control over camera position and ... speed method, frame color, inner color, text, and more. With TransCel the possibilities are ...
(Date:9/4/2015)... ... September 04, 2015 , ... IVF New England, one of the largest ... "ManchVegas Happy Hour" in Manchester for women who wish to learn more about their ... Elm restaurant and lounge, 827 Elm Street, Manchester, NH from 6PM to 7PM , ...
(Date:9/4/2015)... ... September 04, 2015 , ... A Union County ... Core Compassion Project is a non-profit organization dedicated to offering Pilates scholarships ... of cancer treatments and recover their mobility, strength, and range of motion following ...
(Date:9/4/2015)... HI (PRWEB) , ... September 04, 2015 , ... “Getting ... best ways for couples to explore, revitalize and strengthen their ‘couple-ness,’” says Jean ... his team at Four Seasons Resort Maui, the island’s only Forbes Five Star resort ...
(Date:9/4/2015)... ... , ... The USC Eye Institute is proud to announce that the ... residents and staff are honored to have contributed to the success of our program. ... program. Our faculty places a high priority on our educational programs in training the ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios Releases TransCel, a New FCPX Transition 2Health News:IVF New England to Host ManchVegas New Hampshire Fertility Happy Hour on October 15, 2015 in Manchester for Women Who Wish to Learn More About Fertility and Egg Freezing 2Health News:Girl’s Night Out to Benefit Core Compassion Project, Located at the Beautiful, Morning Glory Farm 2Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 2Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 3Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 3
... Campaign Bandana, Dog Owners Get an Opportunity ... Diseases, DENVER, June 16 Camp Bow Wow, ... has launched a fund raising,effort on behalf of Morris ... cure dog cancer,and fight other major dog diseases. Beginning ...
... Camp Bow Wow Doggy Campers Get a Campaign Bandana, ... Save their Dog from Cancer and other Diseases, ... fastest,growing premier doggy day and overnight camp, has launched ... (MAF), http://www.MorrisAnimalFoundation.org, and its campaign to cure dog ...
... Campers Get a Campaign Bandana, Dog Owners Get an ... Cancer and other Diseases, DENVER, June 16 ... and overnight camp, has launched a fund raising,effort on ... its campaign to cure dog cancer,and fight other major ...
... EAGAN, Minn., June 16 The Blue Cross ... in grants under two,initiatives designed to improve the ... Growing Up Healthy: Kids and Communities, $373,000,for Healthy ... in,related grants., Growing Up Healthy, a 10-year ...
... 16 SpectraScience, Inc. (OTC,Bulletin Board: SCIE), a ... appointment of its new Vice President of Sales, ... Adeza Biomedical Specialty,Laboratories, Medigene and most recently at ... than 24 years of sales and,marketing experience in ...
... Activated ... Charcoal, ... quickly approaching, which means one thing ... BBQ season,is officially underway., ... alcohol,-- may leave you gassy during the fireworks extravaganza. Patricia Raymond,M.D., ...
Cached Medicine News:Health News:Camp Bow Wow(R) Launches Fundraising Effort to Help Cure Cancer in Dogs, via Morris Animal Foundation's Canine Cancer Campaign - Dogs Get Bandanas; Camp Bow Wow Locations in Minnesota Participating 2Health News:Camp Bow Wow(R) Launches Fundraising Effort to Help Cure Cancer in Dogs, via Morris Animal Foundation's Canine Cancer Campaign - Dogs Get Bandanas; Camp Bow Wow Locations in Colorado Participating 2Health News:Camp Bow Wow(R) Launches Fundraising Effort to Help Cure Cancer in Dogs, via Morris Animal Foundation's Canine Cancer Campaign - Dogs Get Bandanas 2Health News:Blue Cross Foundation Awards $528,000 in Grants to Improve Community Health 2Health News:Blue Cross Foundation Awards $528,000 in Grants to Improve Community Health 3Health News:Blue Cross Foundation Awards $528,000 in Grants to Improve Community Health 4Health News:Blue Cross Foundation Awards $528,000 in Grants to Improve Community Health 5Health News:SpectraScience Adds Industry Veteran to Executive Team 2Health News:Don't Let Gas Ruin Your Summer BBQ 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: